Cited by 3,187Chronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesInhalation and Respiratory Drug Delivery

The DOI matches its Crossref record; 304 of the 305 references it cites were found in a registry or an index.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

Open access

Vogelmeier, Claus F., Criner, Gerard J., Martinez, Fernando J., Anzueto, Antonio, Barnes, Peter J., Bourbeau, Jean, Celli, Bartolome R., Chen, Rongchang, Decramer, Marc, Fabbri, Leonardo M., Frith, Peter, Halpin, David M. G., López Varela, M. Victorina, Nishimura, Masaharu, Roche, Nicolas, Rodriguez-Roisin, Roberto, Sin, Don D., Singh, Dave, Stockley, Robert, Vestbo, Jørgen, Wedzicha, Jadwiga A., Agustí, Alvar·2017·American Journal of Respiratory and Critical Care Medicine

DOI 10.1164/rccm.201701-0218pp

Open this paper in CoChat — free account Open PDF

Abstract

This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1164/rccm.201701-0218pp

Cites

304 of 304 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,410
Self-citation
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citation
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citation
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citation
A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory Questionnaire
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A. R., Locantore, N., Müllerová, H., Tal‐Singer, R., Miller, B. E., Lomas, D. A., Agustí, A. G. N., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,983
Self-citation
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Self-citation
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
Anthonisen, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,474
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,364

Show all 305 references

Research works printed but not linked: 34

Medical Research Council Committee on the Aetiology of Chronic Bronchitis, 1965, Definition and classification of chronic bronchitis for clinical and epidemiological purposes: a report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis, Lancet, 1, 775
Fletcher, 1960, Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score), BMJ, 2, 1662
National Institute for Health and Care Excellence, 2016, Multimorbidity: clinical assessment and management, in press
1997, Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ, 75, 397
van Eerd, 2016, Smoking cessation for people with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD010744
van der Meer, 2003, Smoking cessation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002999
McNeill, 2015, E-cigarettes: an evidence update
McRobbie, 2014, Electronic cigarettes for smoking cessation and reduction, Cochrane Database Syst Rev, 12, CD010216
Cahill, 2013, Pharmacological interventions for smoking cessation: an overview and network meta-analysis, Cochrane Database Syst Rev, 5, CD009329
Stead, 2013, Physician advice for smoking cessation, Cochrane Database Syst Rev, 5, CD000165
Stead, 2016, Combined pharmacotherapy and behavioural interventions for smoking cessation, Cochrane Database Syst Rev, 3, CD008286
Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002733
Wongsurakiat, 2003, Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients, J Med Assoc Thai, 86, 497
Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1
Appleton, 2006, Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD006101
Karner, 2014, Tiotropium versus placebo for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD009285
Ram, 2002, Oral theophylline for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD003902
Nannini, 2012, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 9, CD006829
Nannini, 2013, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 8, CD006826
Yang, 2012, Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD002991
Chong, 2013, Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 11, CD002309
Poole, 2015, Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001287
Puhan, 2011, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD005305
Kruis, 2013, Integrated disease management interventions for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 10, CD009437
Halpin, 2009, Palliative and end-of-life care for patients with respiratory diseases, Eur Respir Monograph, 43, 327
Cranston, 2005, Domiciliary oxygen for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001744
Barr, 2005, Inhaled tiotropium for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002876
Karner, 2012, Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 4, CD008989
Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 63, 822
Tiong, 2006, Lung volume reduction surgery for diffuse emphysema, Cochrane Database Syst Rev, CD001001
Vollenweider, 2012, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 12, CD010257
Ram, 2006, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD004403
Schuetz, 2012, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, Cochrane Database Syst Rev, CD007498
Bradley, 1985, Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome, Am Rev Respir Dis, 131, 835

Sorted by citations

Items 401–500 of 1,001

Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability
Woodcock, A. A., Boucot, I. H., Leather, D. A., Crawford, J., Collier, S., Bakerly, N. D., Hilton, E., & Vestbo, J. (2018) · European Respiratory Journal · doi:10.1183/13993003.01531-2017 · Cited by 41
Self-citation
Network Modules Uncover Mechanisms of Skeletal Muscle Dysfunction in COPD Patients
Tényi, Á., Cano, I., Marabita, F., Kiani, N., Kalko, S. G., Barreiro, E., de Atauri, P., Cascante, M., Gomez-Cabrero, D., & Roca, J. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1405-y · Cited by 40
Overexpression of Forkhead box C1 attenuates oxidative stress, inflammation and apoptosis in chronic obstructive pulmonary disease
Xia, S., Qu, J., Jia, H. M., He, W., Li, J., Zhao, L., Mao, M., & Zhao, Y. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.11.023 · Cited by 40
Matrine reduces cigarette smoke-induced airway neutrophilic inflammation by enhancing neutrophil apoptosis
Yu, X., Seow, H. J., Wang, H., Anthony, D., Bozinovski, S., Lin, L., Ye, J., & Vlahos, R. (2019) · Clinical Science · doi:10.1042/cs20180912 · Cited by 40
Adherence to a Mediterranean-like Diet as a Protective Factor Against COPD: A Nested Case-Control Study
Fischer, A., Johansson, I., Blomberg, A., & Sundström, B. (2019) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2019.1634039 · Cited by 42
COPD patients need more information about self-management: a cross-sectional study in Swedish primary care
Sandelowsky, H., Krakau, I., Modin, S., Ställberg, B., & Nager, A. (2019) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2019.1684015 · Cited by 40
Intestinal function is impaired in patients with Chronic Obstructive Pulmonary Disease
Kirschner, S. K., Deutz, N. E. P., Jonker, R., Damink, S. W. M. O., Harrykissoon, R., Zachria, A. J., Dasarathy, S., & ENGELEN, M. P. K. J. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.010 · Cited by 40
New bronchoscopic treatment modalities for patients with chronic bronchitis
Hartman, J. E., Garner, J. L., Shah, P. L., & Slebos, D. (2021) · European Respiratory Review · doi:10.1183/16000617.0281-2020 · Cited by 40
Advanced In Vitro Lung Models for Drug and Toxicity Screening: The Promising Role of Induced Pluripotent Stem Cells
Moreira, A., Müller, M., Costa, P. F., & Kohl, Y. (2021) · Advanced Biology · doi:10.1002/adbi.202101139 · Cited by 49
Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases
Fays, C. D., Carlier, F. M., Gohy, S. T., & Pilette, C. (2022) · Cells · doi:10.3390/cells11081324 · Cited by 40
Diaphragm dysfunction detected with ultrasound to predict noninvasive mechanical ventilation failure: A prospective cohort study
Kocyigit, H., Günalp, M., Genç, S., Oğuz, A. B., Koca, A., & Polat, O. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.08.014 · Cited by 40
Screening and staging of chronic obstructive pulmonary disease with deep learning based on chest X-ray images and clinical parameters
Zou, X., Ren, Y., Yang, H., Zou, M., Meng, P., Zhang, L.-Y., Gong, M., Ding, W., Han, L., & Zhang, T. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-02945-7 · Cited by 39
Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation
Jo, Y. S., Yoon, H. I., Kim, D. K., Yoo, C., & Lee, C. (2017) · International Journal of COPD · doi:10.2147/copd.s149805 · Cited by 39
2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group
Högman, M., Sulku, J., Ställberg, B., Janson, C., Bröms, K., Hedenström, H., Lisspers, K., & Malinovschi, A. (2018) · International Journal of COPD · doi:10.2147/copd.s151016 · Cited by 40
Office Spirometry in Primary Care for the Diagnosis and Management of COPD: National Lung Health Education Program Update
Ruppel, G. L., Carlin, B. W., Hart, M., & Doherty, D. E. (2018) · Respiratory Care · doi:10.4187/respcare.05710 · Cited by 39
Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD
on behalf of the AERIS Study Group, Ostridge, K., Williams, N. P., Kim, V., Harden, S. P., Bourne, S. C., Clarke, S. C., Aris, E., Mesía-Vela, S., Devaster, J., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0734-y · Cited by 39
New Spirometry Indices for Detecting Mild Airflow Obstruction
Bhatt, S. P., Bhakta, N. R., Wilson, C. G., Cooper, C. B., Barjaktarević, I., Bodduluri, S., Kim, Y.-I., Eberlein, M. H., Woodruff, P. G., Sciurba, F. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35930-2 · Cited by 39
Red Blood Cell Distribution Width Predicts Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Yang, J., Liu, C., Li, L., Tu, X., & Lu, Z. (2019) · Canadian Respiratory Journal · doi:10.1155/2019/3853454 · Cited by 40
The potential of lipid-polymer nanoparticles as epigenetic and ROS control approaches for COPD
Chikuma, K., Arima, K., Asaba, Y., Kubota, R., Asayama, S., Sato, K., & Kawakami, H. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1696965 · Cited by 39
Nutritional supplementation during pulmonary rehabilitation in COPD: A systematic review
Aldhahir, A. M., Rajeh, A. M. A., Aldabayan, Y. S., Drammeh, S., Subbu, V., Alqahtani, J. S., Hurst, J. R., & Mandal, S. (2020) · Chronic Respiratory Disease · doi:10.1177/1479973120904953 · Cited by 39
Gallic acid ameliorates COPD-associated exacerbation in mice
Singla, E., Puri, G., Dharwal, V., & Naura, A. S. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03905-5 · Cited by 39
Extracellular Vesicles from Airway Secretions: New Insights in Lung Diseases
Pastor, L., Vera, E., Marín, J. M., & Sánz-Rubio, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020583 · Cited by 40
Stem cell therapy for chronic obstructive pulmonary disease
Chen, Y., Miao, K., Zhou, L., & Xiong, W. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001596 · Cited by 39
Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease
Moll, M. R., Boueiz, A. R., Ghosh, A., Saferali, A., Lee, S., Xu, Z., Yun, J. H., Hobbs, B. D., Hersh, C. P., Sin, D. D., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202107-1584oc · Cited by 39
Self-citation
Four different frailty models predict health outcomes in older patients with stable chronic obstructive pulmonary disease
Zhang, D., Tang, W., Dou, L., Luo, J., & Sun, Y. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02750-z · Cited by 39
Impact of Caregiving Burden on Quality of Life of Caregivers of COPD Patients: The Chain Mediating Role of Social Support and Negative Coping Styles
Yi, M., Jiang, D., Jia, Y., Xu, W., Wang, H., Li, Y., Zhang, Z., Wang, J., & Chen, O. (2021) · International Journal of COPD · doi:10.2147/copd.s311772 · Cited by 38
Cycle ergometer and inspiratory muscle training offer modest benefit compared with cycle ergometer alone: a comprehensive assessment in stable COPD patients
Wang, K., Zeng, G., Li, R., Luo, Y., Wang, M., Hu, Y., Xu, W., Zhou, L., Chen, R., & Chen, X. (2017) · International Journal of COPD · doi:10.2147/copd.s140093 · Cited by 42
Self-citation
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
Singh, D., Corradi, M., Spinola, M., Papi, A. A., Usmani, O. S., Scuri, M., Petruzzelli, S., & Vestbo, J. (2017) · International Journal of COPD · doi:10.2147/copd.s146822 · Cited by 38
Self-citation
Associations of total and type-specific physical activity with mortality in chronic obstructive pulmonary disease: a population-based cohort study
Cheng, S. W. M., McKeough, Z. J., Alison, J. A., Dennis, S. M., Hamer, M., & Stamatakis, E. (2018) · BMC Public Health · doi:10.1186/s12889-018-5167-5 · Cited by 39
The role of Th1/Th2 cytokines played in regulation of specific CD 4 + Th1 cell conversion and activation during inflammatory reaction of chronic obstructive pulmonary disease
Sun, J., Liu, T., Yan, Y., Huo, K., Zhang, W., Liu, H., & Shi, Z. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12674 · Cited by 38
Additional Effects of Nutritional Antioxidant Supplementation on Peripheral Muscle during Pulmonary Rehabilitation in COPD Patients: A Randomized Controlled Trial
Gouzi, F., Maury, J., Héraud, N., Molinari, N., Bertet, H., Ayoub, B., Blaquière, M., Bughin, F., De Rigal, P., Poulain, M., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5496346 · Cited by 38
Osteoporosis among patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis of prevalence, severity, and therapeutic outcomes
Khan, A. H., Bitar, A. N., Sulaiman, S. A. S., Ali, I. A. H., & Khan, I. (2019) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_126_19 · Cited by 38
Berberine Attenuates Cigarette Smoke Extract-induced Airway Inflammation in Mice: Involvement of TGF-β1/Smads Signaling Pathway
Wang, W., Zha, G., Zou, J., Wang, X., Li, C., & Wu, X. (2019) · Current Medical Science · doi:10.1007/s11596-019-2101-8 · Cited by 38
Evaluation of Droplet Digital Polymerase Chain Reaction (ddPCR) for the Absolute Quantification of Aspergillus species in the Human Airway
Poh, T. Y., Ali, N. A. B. M., Chan, L., Tiew, P. Y., & Chotirmall, S. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093043 · Cited by 38
Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality
Zhang, Y., Liang, L., Zhang, S., Lu, Y., Chen, Y.-Y., Shi, H., & Lin, Y. (2020) · International Journal of COPD · doi:10.2147/copd.s245056 · Cited by 38
Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease
Liu, D., Meister, M. L., Zhang, S., Vong, C.-I., Wang, S., Fang, R., Li, L., Wang, P. G., Massion, P. P., & Ji, X. (2020) · Respiratory Research · doi:10.1186/s12931-020-01507-9 · Cited by 38
Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects
Xu, Y., Thakur, A., Zhang, Y., & Foged, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020177 · Cited by 38
High-Flow Nasal Cannula Oxygen Therapy versus Non-Invasive Ventilation for AECOPD Patients After Extubation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Feng, Z., Zhang, L., Yu, H., Su, X., Shuai, T., Zhu, L., Chen, D., & Liu, J. (2022) · International Journal of COPD · doi:10.2147/copd.s375107 · Cited by 38
Cigarette Smoke Exposure Induces Neurocognitive Impairments and Neuropathological Changes in the Hippocampus
Dobric, A., Luca, S. N. D., Seow, H. J., Wang, H., Brassington, K., Chan, S. M. H., Mou, K., Erlich, J. R., Liong, S., Selemidis, S., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.893083 · Cited by 37
Underdiagnosis in COPD: a battle worth fighting
Almagro, P., & Soriano, J. B. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30133-9 · Cited by 37
Knockout of RAGE ameliorates mainstream cigarette smoke-induced airway inflammation in mice
Chen, M., Wang, T., Shen, Y., Xu, D., Li, X., An, J., Dong, J., Li, D., Wen, F., & Chen, L. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.06.018 · Cited by 37
Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies
Lin, C., Liu, C., Yeh, C.-C., Chang, Y., Chung, C., Lane, H.-L., Shih, C.-C., Chen, T.-L., & Liao, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181815 · Cited by 37
Variability in objective and subjective measures affects baseline values in studies of patients with COPD
Anderson, W. H., Ha, J. W., Couper, D. J., O’Neal, W. K., Barr, R. G., Bleecker, E. R., Carretta, E. E., Cooper, C. B., Doerschuk, C. M., Drummond, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184606 · Cited by 37
Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot)
Torén, K., Vikgren, J., Olin, A., Rosengren, A., Bergström, G. M. L., & Brandberg, J. (2017) · International Journal of COPD · doi:10.2147/copd.s144933 · Cited by 36
Real-life feasibility and effectiveness of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease requiring medical equipment
Coquart, J. B., Rouzic, O. L., Racil, G., Wallaert, B., & Grosbois, J. (2017) · International Journal of COPD · doi:10.2147/copd.s150827 · Cited by 37
Left ventricular volume and wall stress are linked to lung function impairment in COPD
Alter, P. J., Jörres, R. A., Watz, H., Welte, T., Gläser, S., Schulz, H., Bals, R., Karch, A., Wouters, E. F. �., Vestbo, J., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.02.074 · Cited by 38
Self-citation
Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry
Kobayashi, S., Hanagama, M., Ishida, M., Sato, H., Ono, M., Yamanda, S., Yamada, M., Aizawa, H., & Yanai, M. (2018) · International Journal of COPD · doi:10.2147/copd.s182905 · Cited by 37
A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population
Rodríguez‐Mañero, M., López-Pardo, E., Cordero, A., Ruano‐Raviña, A., Platas, J. N., Pereira‐Vázquez, M., Martínez-Gómez, Á., García‐Seara, J., Martínez‐Sande, J. L., Peña, C., et al. (2019) · International Journal of COPD · doi:10.2147/copd.s174443 · Cited by 37
Anti-Allergic and Anti-Inflammatory Effects and Molecular Mechanisms of Thioredoxin on Respiratory System Diseases
Zhou, J., Wang, C., Wu, J. S., Fukunaga, A., Cheng, Z., Wang, J., Yamauchi, A., Yodoi, J., & Tian, H. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7807 · Cited by 39
New Insights on Pulmonary Paracoccidioidomycosis
Queiroz‐Telles, F., Pietrobom, P. M. P., Júnior, M. R., Baptista, R. D. M., & Peçanha, P. M. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-3400544 · Cited by 37
Perceptions of Home Telemonitoring Use Among Patients With Chronic Obstructive Pulmonary Disease: Qualitative Study
Lundell, S., Modig, M., Holmner, Å., & Wadell, K. (2020) · JMIR mhealth and uhealth · doi:10.2196/16343 · Cited by 39
Perceptions of Patients Regarding Mobile Health Interventions for the Management of Chronic Obstructive Pulmonary Disease: Mixed Methods Study
Alwashmi, M. F., FitzPatrick, B., Farrell, J., Gamble, J., Davis, E., Nguyen, H. V., Farrell, G., & Hawboldt, J. (2020) · JMIR mhealth and uhealth · doi:10.2196/17409 · Cited by 37
Association Between Serum S100A8/S100A9 Heterodimer and Pulmonary Function in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Huang, S.-J., Ding, Z.-N., Xiang, H.-X., Fu, L., & Fei, J. (2020) · Lung · doi:10.1007/s00408-020-00376-9 · Cited by 37
Simulation of nanoparticle transport and adsorption in a microfluidic lung-on-a-chip device
Arefi, S. M. A., Yang, C. W. T., Sin, D. D., & Feng, J. J. (2020) · Biomicrofluidics · doi:10.1063/5.0011353 · Cited by 38
Self-citation
Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer
Chen, J., Li, X., Huang, C., Lin, Y. H., & Dai, Q.-F. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820951807 · Cited by 40
Cigarette smoke extract induces airway epithelial cell death via repressing PRMT6/AKT signaling
Li, T., Fanning, K. V., Nyunoya, T., Chen, Y., & Zou, C. (2020) · Aging · doi:10.18632/aging.202210 · Cited by 37
Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease
Yang, Y., Jin, X., Jiao, X., Li, J.-J., Liang, L., Ma, Y., Liu, R., & Li, Z. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8871105 · Cited by 37
Effects of Home-Based Pulmonary Rehabilitation on Dyspnea, Exercise Capacity, Quality of Life and Impact of the Disease in COPD Patients: A Systematic Review
Xavier, D. M., Galvão, E. L., Fonseca, A. A., de Souza, G. M., & Lima, V. P. (2022) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2021.2020234 · Cited by 42
Meta-analysis and Systematic Review of Bronchoscopic Lung Volume Reduction Through Endobronchial Valves in Severe Emphysema
Patel, M., Chowdhury, J. M., Zhao, H., Lu, X., Roth, S. C., Giovacchini, C. X., Wahidi, M. M., & Criner, G. J. (2022) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0000000000000872 · Cited by 37
Self-citation
ω-3 polyunsaturated fatty acid supplementation improves postabsorptive and prandial protein metabolism in patients with chronic obstructive pulmonary disease: a randomized clinical trial
ENGELEN, M. P. K. J., Jonker, R., Sulaiman, H., Fisk, H. L., Calder, P. C., & Deutz, N. E. P. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac138 · Cited by 39
Looking at the COPD spectrum through “PRISm”
Adibi, A., & Sadatsafavi, M. (2020) · European Respiratory Journal · doi:10.1183/13993003.02217-2019 · Cited by 37
Effect of piperlongumine during exposure to cigarette smoke reduces inflammation and lung injury
Sant’Ana, M., Souza, H. R., Possebon, L., Cornélio, M. L., Riffo‐Vasquez, Y., Girol, A. P., & Oliani, S. M. (2020) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2020.101896 · Cited by 36
Accelerated Lung Function Decline and Mucus–Microbe Evolution in Chronic Obstructive Pulmonary Disease
Meldrum, O. W., Donaldson, G. C., Narayana, J. K., Ivan, F. X., Jaggi, T. K., Aogáin, M. M., Finney, L., Allinson, J. P., Wedzicha, J. A., & Chotirmall, S. H. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202306-1060oc · Cited by 39
Self-citation
Cyclic nucleotide phosphodiesterases as drug targets
Kelly, M. P., Nikolaev, V. O., Gobejishvili, L., Lugnier, C., Heßlinger, C., Nickolaus, P., Kass, D. A., de Vasconcelos, W. P., Fischmeister, R., Brocke, S., et al. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100042 · Cited by 38
Signs of Gas Trapping in Normal Lung Density Regions in Smokers
Bodduluri, S., Reinhardt, J. M., Hoffman, E. A., Newell, J. D., Nath, H. P., Dransfield, M. T., & Bhatt, S. P. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-0855oc · Cited by 36
The Role of Computed Tomography for the Evaluation of Lung Disease in Alpha-1 Antitrypsin Deficiency
Campos, M., & Díaz, A. A. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.11.017 · Cited by 36
Aspergillus fumigatus Detection and Risk Factors in Patients with COPD–Bronchiectasis Overlap
Everaerts, S., Lagrou, K., Vermeersch, K., Dupont, L., Vanaudenaerde, B. M., & Janssens, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020523 · Cited by 36
Relationship between depression and lung function in the general population in Korea: a retrospective cross-sectional study
Park, Y., Jung, J. Y., Kim, Y. S., Chung, K. S., Song, J. H., Kim, S. Y., Kim, E. Y., Kang, Y. A., Park, M. S., Chang, J., et al. (2018) · International Journal of COPD · doi:10.2147/copd.s169025 · Cited by 38
Blood eosinophil count as a prognostic biomarker in COPD
Oh, Y., Lee, K. S., Hong, Y., Hwang, S. C., Kim, J. Y., Kim, D. K., Yoo, K. H., Lee, J.-H., Kim, T., Lim, S. Y., et al. (2018) · International Journal of COPD · doi:10.2147/copd.s179734 · Cited by 36
Can the COPD web be used to promote self-management in patients with COPD in swedish primary care: a controlled pragmatic pilot trial with 3 month- and 12 month follow-up
Nyberg, A., Tistad, M., & Wadell, K. (2019) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2019.1569415 · Cited by 36
End-of-Life Health Care Utilization Between Chronic Obstructive Pulmonary Disease and Lung Cancer Patients
Kuo, L.-C., Chen, J.-H., Lee, C., Tsai, C., & Lin, C.-C. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2019.01.011 · Cited by 36
Effects of Mediterranean Diet and Physical Activity on Pulmonary Function: A Cross-Sectional Analysis in the ILERVAS Project
Gutiérrez-Carrasquilla, L., Sánchez, E., Hernández, M., Polanco, D., Salas‐Salvadó, J., Betriu, À., Gaeta, A. M., Carmona, P., Purroy, F. F., Pamplona, R., et al. (2019) · Nutrients · doi:10.3390/nu11020329 · Cited by 36
Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema
Slebos, D., Cicenia, J. C., Sciurba, F. C., Criner, G. J., Hartman, J. E., Garner, J. L., Deslée, G., Delage, A., Jantz, M. A., Marquette, C., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.02.012 · Cited by 36
Self-citation
Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To Pseudomonas aeruginosa: A Retrospective Cohort Study
Montón, C., Prina, E., Pomares, X., Cugat, J. R., Casabella, A., Oliva, J. C., Gallego, M., & Monsó, E. (2019) · International Journal of COPD · doi:10.2147/copd.s209513 · Cited by 36
Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
Calverley, P. M. A., Page, C. P., Negro, R. W. D., Fontana, G. A., Cazzola, M., Cicero, A. F. G., Pozzi, E., & Wedzicha, J. A. (2019) · International Journal of COPD · doi:10.2147/copd.s221852 · Cited by 36
Self-citation
Role of Regulatory T Cells in Disturbed Immune Homeostasis in Patients With Chronic Obstructive Pulmonary Disease
Hou, J., & Sun, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00723 · Cited by 38
Computed Tomography–based Airway Surface Area–to-Volume Ratio for Phenotyping Airway Remodeling in Chronic Obstructive Pulmonary Disease
Bodduluri, S., Puliyakote, A. S. K., Nakhmani, A., Charbonnier, J., Reinhardt, J. M., & Bhatt, S. P. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-0951oc · Cited by 36
Monocyte-derived dendritic cells link localized secretory IgA deficiency to adaptive immune activation in COPD
Richmond, B. W., Mansouri, S., Serezani, A. P. M., Novitskiy, S. V., Blackburn, J. B., Du, R., Fuseini, H., Gutor, S. S., Han, W., Schaff, J., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00344-9 · Cited by 36
Optimal NIV Medicare Access Promotion: Patients With COPD
Hill, N. S., Criner, G. J., Branson, R. D., Celli, B. R., MacIntyre, N. R., Sergew, A., Gay, P. C., Owens, R. L., Wolfe, L. F., Benditt, J. O., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.082 · Cited by 36
Self-citation
Obesity and Metabolic Abnormalities in Chronic Obstructive Pulmonary Disease
Wouters, E. F. �. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201705-371aw · Cited by 39
Mortality and vertebral fracture risk associated with long-term oral steroid use in patients with chronic obstructive pulmonary disease: A systemic review and meta-analysis
Chang, Y.-P., Lai, C., Lin, C.-Y., Chang, Y.-C., Lin, M., Chong, I., Sheu, C., Wei, Y., Chu, K., Tsai, J., et al. (2019) · Chronic Respiratory Disease · doi:10.1177/1479973119838280 · Cited by 35
Fully integrating pathophysiological insights in COPD: an updated working disease model to broaden therapeutic vision
Walters, E. H., Shukla, S. D., Mahmood, M. Q., & Ward, C. (2021) · European Respiratory Review · doi:10.1183/16000617.0364-2020 · Cited by 36
Correlation Analysis of Early Renal Injury in Elderly Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Zhang, D. (2022) · International Journal of COPD · doi:10.2147/copd.s377847 · Cited by 35
Impact of Body Composition and Sarcopenia on Mortality in Chronic Obstructive Pulmonary Disease Patients
Gómez-Martínez, M., Rodríguez-García, W., González-Islas, D., Orea-Tejeda, A., Keirns-Davis, C., Salgado-Fernández, F., Hernández-López, S., Jiménez-Valentín, A., Rios-Pereda, A., Marquez-Cordero, J., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041321 · Cited by 32
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry
Tsubouchi, K., Hamada, N., Tokunaga, S., Ichiki, K., Takata, S., Ishii, H., Kitasato, Y., Okamoto, M., Kawakami, S., Yatera, K., et al. (2023) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-001864 · Cited by 37
Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio
Cardoso, J., Coelho, R. D., Rocha, C., Coelho, C., Semedo, L., & de Almeida, A. B. (2018) · International Journal of COPD · doi:10.2147/copd.s155848 · Cited by 36
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort
Labaki, W. W., Xia, M., Murray, S., Curtis, J. L., Barr, R. G., Bhatt, S. P., Bleecker, E. R., Hansel, N. N., Cooper, C. B., Dransfield, M. T., et al. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.06.005 · Cited by 35
Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort
for the SPIROMICS investigators, Bhatt, S. P., Nath, H. P., Kim, Y.-I., Ramachandran, R., Watts, J. R., Terry, N. L. J., Sonavane, S. K., Deshmane, S. P., Woodruff, P. G., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0946-1 · Cited by 35
Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort
Iyer, A. S., Holm, K. E., Bhatt, S. P., Kim, V., Kinney, G. L., Wamboldt, F. S., Jacobs, M. R., Regan, E. A., Armstrong, H. F., Lowe, K., et al. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.01.002 · Cited by 34
Resting hyperinflation and emphysema on the clinical course of COPD
Kim, Y. W., Lee, C., Hwang, H.-G., Kim, Y., Kim, D. K., Oh, Y., Lee, S. H., Kim, K. U., & Lee, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40411-1 · Cited by 35
Chronic Bronchitis: Where Are We Now?
Dotan, Y., So, J. Y., & Kim, V. (2019) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.6.2.2018.0151 · Cited by 35
Expressions of MMP-12, TIMP-4, and Neutrophil Elastase in PBMCs and Exhaled Breath Condensate in Patients with COPD and Their Relationships with Disease Severity and Acute Exacerbations
Hao, W., Li, M., Zhang, Y., Zhang, C., & Xue, Y. (2019) · Journal of Immunology Research · doi:10.1155/2019/7142438 · Cited by 35
Low Vitamin K Status Is Associated with Increased Elastin Degradation in Chronic Obstructive Pulmonary Disease
Piscaer, I., van den Ouweland, J. M. W., Vermeersch, K., Reynaert, N. L., Franssen, F. M. E., Keene, S. J., Wouters, E. F. �., Janssens, W., Vermeer, C., & Janssen, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081116 · Cited by 35
Lung function and paper dust exposure among workers in a soft tissue paper mill
Andersson, E., Sällsten, G., Lohman, S., Neitzel, R. L., & Torén, K. (2019) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-019-01469-6 · Cited by 35
Comprehensive metabolic flux analysis to explain skeletal muscle weakness in COPD
ENGELEN, M. P. K. J., Jonker, R., Thaden, J. J., Have, G. A. M. T., Jeon, M. S., Dasarathy, S., & Deutz, N. E. P. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.01.010 · Cited by 35
Exercise & Sports Science Australia (ESSA) position statement on exercise and chronic obstructive pulmonary disease
Morris, N. R., Hill, K., Walsh, J., & Sabapathy, S. (2020) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2020.08.007 · Cited by 35
Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran
Kiani, F. Z., & Ahmadi, A. (2021) · Scientific Reports · doi:10.1038/s41598-020-79707-y · Cited by 35
The different phenotypes of COPD
Yousuf, A., McAuley, H., Elneima, O., & Brightling, C. E. (2021) · British Medical Bulletin · doi:10.1093/bmb/ldaa043 · Cited by 39
Association between exposure to polycyclic aromatic hydrocarbons and lipid peroxidation in patients with chronic obstructive pulmonary disease
Liu, J., Chen, X., Qiu, X., Zhang, H., Lu, X., Li, H., Chen, W., Zhang, L., Que, C., & Zhu, T. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146660 · Cited by 36
Circulating white blood cells and lung function impairment: the observational studies and Mendelian randomization analysis
Wu, X., Wang, C., Li, H., Meng, H., Jie, J., Fu, M., Bai, Y., Li, G., Wei, W., Feng, Y., et al. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1948603 · Cited by 37

Authors: Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Agustí, A.
Affiliations: Philipps University of Marburg (DE)
Temple University (US)
New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
The University of Texas at San Antonio Health Science Center (US)
Imperial College London (GB)
McGill University Health Centre (CA)
Brigham and Women’s Hospital, Boston, Massachusetts
First Affiliated Hospital of Guangzhou Medical University (CN)
KU Leuven (BE)
University of Modena and Reggio Emilia (IT)
Flinders University (AU)
Royal Devon and Exeter Hospital (GB)
Universidad de la República, Hospital Maciel, Montevideo, Uruguay
Hokkaido University (JP)
Hôpital Cochin (Assistance Publique–Hôpitaux de Paris), University Paris Descartes, Paris, France
Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain
University of British Columbia (CA)
University Hospital, Birmingham, United Kingdom; and
University of Manchester (GB)
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
Corresponding author: Vogelmeier, Claus F.
ORCID: Vogelmeier, Claus F.
Criner, Gerard J.
Anzueto, Antonio
Barnes, Peter J.
Bourbeau, Jean
Chen, Rongchang
Fabbri, Leonardo M.
Frith, Peter
Halpin, David M. G.
Nishimura, Masaharu
Sin, Don D.
Singh, Dave
Stockley, Robert
Vestbo, Jørgen
Wedzicha, Jadwiga A.
Agustí, Alvar
Venue: American Journal of Respiratory and Critical Care Medicine
Publisher: Oxford University Press (OUP)
Published: 2017-03-01
Volume: 195
Issue: 5
Pages: 557-582
ISSN: 1073-449X (ISSN-L)
1535-4970
DOI: 10.1164/rccm.201701-0218pp
OpenAlex: W2583265473
Cited by: 3,187
References: 305
Citations by year: 2026: 118 · 2025: 162 · 2024: 247 · 2023: 307 · 2022: 415 · 2021: 441 · 2020: 449 · 2019: 436 · 2018: 428 · 2017: 173
FWCI: 336.54
Type: journal article
Language: en
Open access: green
lirias.kuleuven.be
Licence: other-oa
academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: American Journal of Respiratory and Critical Care Medicine (publishedVersion)
PubMed (publishedVersion)
Lirias (KU Leuven) (submittedVersion, other-oa)
Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
Spiral (Imperial College London) (submittedVersion)
Funders: National Institute for Health and Care Research (NF-SI-0510-10270, NF-SI-0513-10077, NF-SI-0611-10148)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords: chronic obstructive pulmonary disease, GOLD 2017, COPD diagnosis, COPD management, COPD prevention, exacerbations, non-pharmacological treatment, comorbidities, spirometry, symptom assessment
MeSH terms: Bronchodilator Agents, Humans, Risk Factors, Spirometry, Global Health, Pulmonary Disease, Chronic Obstructive, Internationality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks